Pomalidomide-Dexamethasone in the Management of Heavily Pretreated Multiple Myeloma

被引：0
|
作者：
Cerchione, Claudio [1 ]
Martinelli, Giovanni [2 ]
Nappi, Davide [3 ]
Pareto, Anna Emanuele [3 ]
Di Perna, Maria [3 ]
Ronconi, Sonia [4 ]
Pane, Fabrizio [3 ]
Catalano, Lucio [5 ]
机构：
[1] IRCCS, IRST, Meldola, FC, Italy
[2] IRCCS, Ist Sci Romagnolo Studio & Cura Tumori IRST, Hematol Unit, Meldola, FC, Italy
[3] AOU Federico II, Naples, Italy
[4] European Myeloma Network Italy, GIMEMA, Meldola, Italy
[5] AOU Federico II, GIMEMA, Naples, Italy
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2019年 / 19卷 / 10期
关键词：
Heavily pretreated; Pomalidomide; Real-World Data;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
SP-309
引用
收藏
页码：E359 / E359
页数：1
相关论文
共 50 条
  • [31] Bendamustine-Bortezomib-Dexamethasone in Heavily Pretreated Multiple Myeloma
    Cerchione, Claudio
    Catalano, Lucio
    Nappi, Davide
    Pareto, Anna Emanuele
    Basile, Santina
    Marano, Luana
    Peluso, Ilaria
    Simeone, Luigia
    Vitagliano, Orsola
    Palmieri, Salvatore
    Rocco, Stefano
    Pane, Fabrizio
    Ferrara, Felicetto
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 : S254 - S255
  • [32] Melflufen and Dexamethasone in Heavily Pretreated Relapsed and Refractory Multiple Myeloma
    Richardson, Paul G.
    Oriol, Albert
    Larocca, Alessandra
    Blade, Joan
    Cavo, Michele
    Rodriguez-Otero, Paula
    Leleu, Xavier
    Nadeem, Omar
    Hiemenz, John W.
    Hassoun, Hani
    Touzeau, Cyrille
    Alegre, Adrian
    Paner, Agne
    Maisel, Christopher
    Mazumder, Amitabha
    Raptis, Anastasios
    Moreb, Jan S.
    Anderson, Kenneth C.
    Laubach, Jacob P.
    Thuresson, Sara
    Thuresson, Marcus
    Byrne, Catriona
    Harmenberg, Johan
    Bakker, Nicolaas A.
    Mateos, Maria-Victoria
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (07) : 757 - +
  • [33] PEGFILGRASTIM VERSUS FILGRASTIM IN THE MANAGEMENT OF THERAPY RELATED NEUTROPENIA IN RELAPSED AND REFRACTORY MULTIPLE MYELOMA IN TREATMENT WITH POMALIDOMIDE-DEXAMETHASONE
    Cerchione, C.
    Nappi, D.
    Pareto, A. E.
    Picardi, M.
    Pane, F.
    Catalano, L.
    HAEMATOLOGICA, 2018, 103 : S129 - S129
  • [34] Pomalidomide-dexamethasone for treatment of soft-tissue plasmacytomas in patients with relapsed/refractory multiple myeloma
    Jimenez-Segura, Raquel
    Granell, Miquel
    Gironella, Merce
    Abella, Eugenia
    Garcia-Guinon, Antoni
    Oriol, Albert
    Cabezudo, Elena
    Clapes, Victoria
    Alfons Soler, Joan
    Escoda, Lourdes
    Lopez-Pardo, Jordi
    Fernandez de Larrea, Carlos
    Teresa Cibeira, Maria
    Tovar, Natalia
    Isola, Ignacio
    Blade, Joan
    Rosinol, Laura
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2019, 102 (05) : 389 - 394
  • [35] Isatuximab with pomalidomide-dexamethasone in relapsed/refractory multiple myeloma: post-marketing surveillance in Japan
    Tagami, Nami
    Uchiyama, Michihiro
    Suzuki, Kenshi
    Shirai, Heigoroh
    Seto, Takeshi
    Nishina, Satoshi
    Iida, Shinsuke
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2024, 120 (02) : 217 - 228
  • [36] Pegfilgrastim versus Filgrastim in the Management of Therapy-Related Neutropenia in Relapsed and Refractory Multiple Myeloma in Treatment with Pomalidomide-Dexamethasone
    Cerchione, Claudio
    Nappi, Davide
    Pareto, Anna Emanuele
    Pane, Fabrizio
    Catalano, Lucio
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 : S255 - S256
  • [37] Pegfilgrastim Versus Filgrastim in the Management of Therapy-Related Neutropenia in Relapsed and Refractory Multiple Myeloma in Treatment with Pomalidomide-Dexamethasone
    Cerchione, Claudio
    Nappi, Davide
    Pane, Fabrizio
    Catalano, Lucio
    BLOOD, 2018, 132
  • [38] Long-Term Exposure to Pomalidomide-Dexamethasone in Pts with Refractory Myeloma
    Pegourie, Brigitte
    Petillon, Marie Odile
    Karlin, Lionel
    Caillot, Denis
    Roussel, Murielle
    Arnulf, Bertrand
    Mathiot, Claire
    Marit, Gerald
    Macro, Margaret
    Kolb, Brigitte
    Stoppa, Anne-Marie
    Brechiniac, Sabine
    Garderet, Laurent
    Royer, Bruno
    Hulin, Cyril
    Benbouker, Lotfi B.
    Decaux, Olivier
    Escoffre-Barbe, Martine
    Fermand, Jean Paul
    Moreau, Philippe
    Avet-Loiseau, Herve
    Attal, Michel
    Facon, Thierry
    Leleu, Xavier
    BLOOD, 2014, 124 (21)
  • [39] BENDAMUSTINE-BORTEZOMIB-DEXAMETHASONE (BVD) IN HEAVILY PRETREATED MULTIPLE MYELOMA
    Cerchione, C.
    Catalano, L.
    Nappi, D.
    Pareto, A. E.
    Basile, S.
    Marano, L.
    Peluso, I.
    Simeone, L.
    Vitagliano, O.
    Palmieri, S.
    Rocco, S.
    Ferrara, F.
    Pane, F.
    HAEMATOLOGICA, 2018, 103 : S86 - S86
  • [40] Selinexor, Bortezomib, and Dexamethasone for Heavily Pretreated Multiple Myeloma: A Case Series
    Magen, Hila
    Geva, Mika
    Volchik, Yulia
    Avigdor, Abraham
    Nagler, Arnon
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 (12): : E947 - E955
12345